Mesenchymal stem cell abnormalities in patients with multiple myeloma

Leukemia and Lymphoma

Volumn 48, Issue 10, 2007, Pages 2032-2041

  Garderet, Laurent ^a,b   Mazurier, Christelle ^a   Chapel, Alain ^a,c   Ernou, Isabelle ^d   Boutin, Laetitia ^d   Holy, Xavier ^e   Gorin, Norbert Claude ^a,b   Lopez, Manuel ^a   Doucet, Christelle ^d   Lataillade, Jean Jacques ^d  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^d Jean Julliard Army Centre for Blood Transfusion   (France)

^e Army Department   (France)

Author keywords

Bone lesions; Mesenchymal stem cells; Multiple myeloma; Osteoblasts

Indexed keywords

CELL PROTEIN; DICKKOPF FACTOR; GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DEVELOPMENT; BONE LESION; BONE MARROW CELL; CELL FUNCTION; CELL GROWTH; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; BONE AND BONES; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; MULTIPLE MYELOMA; OSTEOBLASTS; OSTEOCLASTS; OSTEOLYSIS; SYNDECAN-1;

EID: 35148897797     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701593644     Document Type: Article

References (25)

1. Kyle, R. A. and Rajkumar, S. V. (2004) Multiple myeloma. N Engl J Med, 351, pp. 1860-1873.
2. Kuehl, W. and Bergsagel, P. L. (2002) Multiple myeloma: Evolving genetic events and host interactions. Nat Rev Cancer, 2, pp. 175-187.
3. Terpos, E., Politou, M. and Rahemtulla, A. (2003) New insights into the pathophysiology and management of bone disease in multiple myeloma. Br J Haematol, 123, pp. 758-769.
4. Taube, T., Beneton, M NC, McCloskey, E. V., Rogers, S., Greaves, M. and Kanis, J. A. (1992) Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. Eur J Haematol, 49, pp. 192-198.
5. Klein, B., Zhang, X. and Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, pp. 863-872.
6. Heider, U., Hofbauer, L. C., Zavrski, I., Kaiser, M., Jakob, C. and Sezer, O. (2005) Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease. Biochem Biophys Res Commun, 338, pp. 687-693.
7. Giuliani, N., Rizzoli, V. and Roodman, G. D. (2006) Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. Blood, 108, pp. 3992-3996.
8. Wallace, S. R., Oken, M. M., Lunetta, K. L., Panoskaltsis-mortari, A. and Masellis, A. M. (2001) Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients. Cancer, 91, pp. 1219-1230.
9. Giuliani, N., Colla, S., Morandi, F., Lazzaretti, M., Sala, R. and Bonomini, S. (2005) Myeloma cells block Runx2/Cbfa1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation. Blood, 106, pp. 2472-2483.
10. Tian, E., Zhan, F., Walker, R., Rasmussen, E. and Barlogie, B. (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med, 349, pp. 2483-2494.
11. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R. and Mosca, J. D. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, pp. 143-147.
12. Doucet, C., Ernou, I., Zhang, Y., Llense, J. R., Begot, L. and Holy, X. (2005) Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J Cell Physiol, 205, pp. 228-236.
13. Pfaffl, M. W., Horgan, G. W. and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res, 30, p. e36.
14. Conget, P. A. and Minguell, J. J. (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol, 181, pp. 67-73.
15. D'Ippolito, G., Schiller, P. C., Ricordi, C., Roos, B. A. and Howard, G. A. (1999) Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res, 14, pp. 1115-1122.
16. Arnulf, B., Lecourt, S., Soulier, J., Ternaux, B., Lacassagne, M. N. and Crinquette, A. (2007) Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia, 21, pp. 156-163.
17. Haaber, J., Knudsen, L. M., Dahl, I. M., Abildgaard, N., Lodahl, M. and Rasmussen, T. (2006) Myeloma cell expression of candidate genes for osteolytic bone disease - over-expression of DKK1 correlates with clinical bone involvement. Blood, 108
18. Yaccoby, S., Ling, W., Zhan, F., Walker, R., Barlogie, B. and Shaughnessy jr, J. D. (2007) Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood, 109, pp. 2106-2111.
19. Westendorf, J. J., Kahler, R. A. and Schroeder, T. M. (2004) Wnt signaling in osteoblasts and bone diseases. Gene, 341, pp. 19-39.
20. Gregory, C. A., Perry, A. S., Reyes, E., Conley, A., Gunn, W. G. and Prockop, D. J. (2005) Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. J Biol Chem, 280, pp. 2309-2323.
21. Gunn, W. G., Conley, A., Deininger, L., Olson, S. D., Prockop, D. J. and Gregory, C. A. (2005) A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and IL-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells, 2, pp. 986-991.
22. Lokhorst, H. M., Lamme, T., de Smet, M., Klein, S., de Werger, R. A. and Van Oers, R. (1994) Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84, pp. 2269-2277.
23. Rigolin, G. M., Fraulini, C., Ciccone, M., Mauro, E., Bugli, A. M. and De Angeli, C. (2006) Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood, 107, pp. 2531-2535.
24. Blanc, K Le and Pittenger, M. (2005) Mesenchymal stem cells: Progress toward promise. Cytotherapy, 7, pp. 36-45.
25. Horwitz, E. M., Gordon, P. L., Koo, W. K., Marx, J. C., Neel, M. D. and McNall, R. Y. (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA, 99, pp. 8932-8937.